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Background
The incidence and prevalence of HIV infection among
adolescents and young adults in South Africa is high.
National seroprevalence surveys estimate the prevalence
of HIV among 15–24 year olds to be 15.5% amongst
females and 4.8% amongst males. Despite current socio-
behavioural efforts, HIV infection rates have not shown a
significant decline. Should a biomedical intervention be
efficacious with adults it will be critical to test this product
in adolescents and young adults. We examined adolescent
willingness to participate in future HIV prevention trials.
Methods
The willingness to participate questionnaire formed part
of a larger adolescent survey conducted with 16–18 year
old adolescents living in Soweto, an urban African setting.
Participants were asked about their perceived risk of HIV
and their willingness to participate in HIV prevention tri-
als.
Results
In total 303 questionnaires were administered with a sam-
ple of 176 females and 127 males between 16 and 18
years (median age = 17). 93% (n = 282) reported ever hav-
ing a partner. 50% (n = 88) of the females and 62% (n =
79) of the males reported sexual activity (vaginal, anal or
oral sex). 31% (n = 96) reported that they were likely to
become infected with HIV while 45% (n = 138) indicated
that they were not at all likely to become infected with
HIV. There was an association between condom use and
perceived risk of HIV (p < 0.003) as well as gender and
willingness to participate in HIV prevention trials (p <
0.009). 90% (n = 273) indicated willingness to participate
in vaccine trials. 70% of the participants thought that ado-
lescents in their community would be willing to partici-
pate in a vaccine trial. 88% (n = 155) of females and 77%
(n = 98) of the males indicated a willingness to participate
in microbicide and circumcision trials respectively.
Conclusion
The findings show encouraging results of adolescent will-
ingness to participate in future HIV prevention.
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